[the_ad id="21475"]
[ad_1]
Guardion Health Sciences (GHSI) is scheduled to report 4th quarter earnings on 04/03/2023.
Regarding Q4 estimates, Wall Street analysts expect Guardion Health Sciences to post earnings of -$0.03 per share. Revenue expectations are pegged at $2.7 million. Last quarter, Guardion Health Sciences missed earnings estimates, reporting EPS of -$0.03 on estimates of -$0.03. The stock fell by -8.82% the day after the last earnings release.
Year-to-date, GHSI stock has fallen by -15.84%.
About Guardion Health Sciences
Guardion Health Sciences, Inc. provides health care services. It offers, Lumega-Z a medical food formulated to replenish and restore the macular protective pigment. The firm also develops medical devices that measures macular pigment density. The company was founded by Michael Favish in 2009 and is headquartered in San Diego, CA.
Stay up-to-date on earnings this week, with TipRanks’ Earnings Calendar.
Click Here to Read the Full Original Article at TipRanks Financial Blog…
[ad_2]
[the_ad id="21476"]